Novocure Stock Odds of Future Stock Price Finishing Under 12.73

NVCR Stock  USD 17.73  0.64  3.74%   
Novocure's future price is the expected price of Novocure instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Novocure performance during a given time horizon utilizing its historical volatility. Check out Novocure Backtesting, Novocure Valuation, Novocure Correlation, Novocure Hype Analysis, Novocure Volatility, Novocure History as well as Novocure Performance.
To learn how to invest in Novocure Stock, please use our How to Invest in Novocure guide.
  
As of 11/22/2024, Price To Sales Ratio is likely to drop to 2.96. In addition to that, Price Earnings Ratio is likely to drop to -8.06. Please specify Novocure's target price for which you would like Novocure odds to be computed.

Novocure Target Price Odds to finish below 12.73

The tendency of Novocure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 12.73  or more in 90 days
 17.73 90 days 12.73 
near 1
Based on a normal probability distribution, the odds of Novocure to drop to $ 12.73  or more in 90 days from now is near 1 (This Novocure probability density function shows the probability of Novocure Stock to fall within a particular range of prices over 90 days) . Probability of Novocure price to stay between $ 12.73  and its current price of $17.73 at the end of the 90-day period is about 77.35 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.39 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Novocure will likely underperform. Additionally Novocure has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Novocure Price Density   
       Price  

Predictive Modules for Novocure

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Novocure. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novocure's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
12.7317.0921.45
Details
Intrinsic
Valuation
LowRealHigh
10.0214.3818.74
Details
Naive
Forecast
LowNextHigh
12.0916.4520.81
Details
7 Analysts
Consensus
LowTargetHigh
51.4856.5762.79
Details

Novocure Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Novocure is not an exception. The market had few large corrections towards the Novocure's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Novocure, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Novocure within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.19
β
Beta against Dow Jones2.39
σ
Overall volatility
1.21
Ir
Information ratio -0.01

Novocure Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Novocure for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Novocure can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Novocure had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 509.34 M. Net Loss for the year was (207.04 M) with profit before overhead, payroll, taxes, and interest of 423.58 M.
Novocure currently holds about 948.52 M in cash with (73.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.06.
Over 87.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields Therapy in Glioblastoma

Novocure Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Novocure Stock often depends not only on the future outlook of the current and potential Novocure's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novocure's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding106.4 M
Cash And Short Term Investments910.6 M

Novocure Technical Analysis

Novocure's future price can be derived by breaking down and analyzing its technical indicators over time. Novocure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Novocure. In general, you should focus on analyzing Novocure Stock price patterns and their correlations with different microeconomic environments and drivers.

Novocure Predictive Forecast Models

Novocure's time-series forecasting models is one of many Novocure's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Novocure's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Novocure

Checking the ongoing alerts about Novocure for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Novocure help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Novocure had very high historical volatility over the last 90 days
The company reported the previous year's revenue of 509.34 M. Net Loss for the year was (207.04 M) with profit before overhead, payroll, taxes, and interest of 423.58 M.
Novocure currently holds about 948.52 M in cash with (73.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.06.
Over 87.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Novocure Data at 2024 SNO Annual Meeting Highlights Product Innovation and Real-World Evidence for Tumor Treating Fields Therapy in Glioblastoma

Additional Tools for Novocure Stock Analysis

When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.